Assignee
MEDEOR THERAPEUTICS INC
US·7 granted patents·10 pending applications·11 citations·filing 2018–2023
Top patents by PatentIndex Score
17 records- 0181US11819521B2Cellular compositions derived from prior organ donors and methods of manufacture and use thereofMEDEOR THERAPEUTICS INC·Filed 2020·Granted Nov 21, 2023·1 cites·19 claims
- 0281US11435350B2Methods of analysis of blood from deceased donorsMEDEOR THERAPEUTICS INC·Filed 2019·Granted Sep 6, 2022·3 cites·14 claims
- 0379US10881692B2Compositions for establishing mixed chimerism and methods of manufacture thereofMEDEOR THERAPEUTICS INC·Filed 2018·Granted Jan 5, 2021·3 cites·30 claims
- 0479US10842821B2Cellular compositions derived from prior organ donors and methods of manufacture and use thereofMEDEOR THERAPEUTICS INC·Filed 2018·Granted Nov 24, 2020·3 cites·9 claims
- 0575US11813376B2Cellular compositions derived from deceased donors to promote graft tolerance and manufacture and uses thereofMEDEOR THERAPEUTICS INC·Filed 2019·Granted Nov 14, 2023·1 cites·11 claims
- 0673US2024115617A1Cellular compositions derived from prior organ donors and methods of manufacture and use thereofMEDEOR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0772US2023302057A1Compositions for establishing mixed chimerism and methods of manufacture thereofMEDEOR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0866US11701392B2Compositions for establishing mixed chimerism and methods of manufacture thereofMEDEOR THERAPEUTICS INC·Filed 2020·Granted Jul 18, 2023·0 cites·20 claims
- 0965US2024115769A1Cellular compositions derived from deceased donors to promote graft tolerance and manufacture and uses thereofMEDEOR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1065US2022412973A1Methods of analysis of blood from deceased donorsMEDEOR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1164US11273179B2Methods for treating non-cancerous disorders using hematopoietic cellsMEDEOR THERAPEUTICS INC·Filed 2019·Granted Mar 15, 2022·0 cites·22 claims
- 1263US2022152113A1Methods for treating non-cancerous disorders using hematopoietic cellsMEDEOR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1361US2024108655A1Methods of producing mixed chimerism after a solid organ transplantMEDEOR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1450US2023201256A1Calcineurin inhibitor to improve cd3+cell survival to thereby facilitate engraftment of donor cd34+ cells in a recipientMEDEOR THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1545US2020086004A1Methods of making cellular compositions derived from deceased donors to promote graft toleranceMEDEOR THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1645US2022305057A1Methods of making cellular products by post- mortem mobilization and harvesting of hematopoietic cellsMEDEOR THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1743US2020087627A1Methods of extracting hematopoietic cells from bone marrow ex vivoMEDEOR THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MEDEOR THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →